Marit Health | $3,200,000 | (Apr 1, 2025)
Inspiren | $35,000,000 | (Apr 1, 2025)
BetterFleet | $15,000,000 | (Apr 1, 2025)
Certified by Founder
Lodge
XyloCor Therapeutics, Inc.
start up
United States
- King of Prussia, Pennsylvania
- 09/01/2025
- Series B
- $67,500,000
XyloCor Therapeutics is a development-stage, biotechnology company dedicated to developing first-in-class gene therapies for patients with unmet medical need in cardiovascular disease.
- Industry Research Services
- Website https://www.xylocor.com/
- LinkedIn https://www.linkedin.com/company/xylocor-therapeutics-inc./
Isomorphic Labs | $600,000,000 | (Apr 1, 2025)
Sohar Health (YC S23) | $3,800,000 | (Apr 1, 2025)
Retym, Inc | $75,000,000 | (Apr 1, 2025)
Ribbon | $8,000,000 | (Apr 1, 2025)
DeepIP | $15,000,000 | (Apr 1, 2025)
Kay.ai | $3,000,000 | (Apr 1, 2025)
GridPoint | $45,000,000 | (Apr 1, 2025)
POCKLA | $1,728,856 | (Apr 1, 2025)
mo:re | $2,485,277 | (Apr 1, 2025)